Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau

BACKGROUND: Aberrant hyperphosphorylation of tau protein has been implicated in a variety of neurodegenerative disorders. Although a number of protein kinases have been shown to phosphorylate tau in vitro and in vivo, the molecular mechanisms by which tau phosphorylation is regulated pathophysiologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xue, Zhang, Yun-wu, Liu, Shijie, Bulloj, Ayelen, Tong, Gary G, Zhang, Zhuohua, Liao, Francesca-Fang, Xu, Huaxi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559623/
https://www.ncbi.nlm.nih.gov/pubmed/16930454
http://dx.doi.org/10.1186/1750-1326-1-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559623/
https://www.ncbi.nlm.nih.gov/pubmed/16930454
http://dx.doi.org/10.1186/1750-1326-1-7

Ejemplares similares